Committees

SLAS Finance Committee

The SLAS Finance Committee ensures that the society’s financial resources are used to advance the society’s tax exempt purposes by developing and recommending the SLAS annual budget for consideration and final approval by the SLAS Board of Directors. Throughout the fiscal year, the committee then monitors actual financial performance and compares it with the budget plan.

2012 Members

SLAS Treasurer and Chair
Erik Rubin, Bristol-Myers Squibb

Robyn Rourick, Genentech
Jason Abbas, Syngenta
Craig Schulz, Amgen
Vicky Vydra, Bristol-Myers Squibb